Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,750 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bioequivalence Study Comparing Fixed-Dose Combination of Clopidogrel and Aspirin with Coadministration of Individual Formulations in Chinese Subjects Under Fed Conditions: A Phase I, Open-Label, Randomized, Crossover Study.
Li Y, Ming JE, Kong F, Yin H, Zhang L, Bai H, Liu H, Qi L, Wang Y, Xie F, Yang N, Ping C, Li Y, Chen L, Han C, Liu J, Wang X. Li Y, et al. Among authors: qi l. Adv Ther. 2020 Nov;37(11):4660-4674. doi: 10.1007/s12325-020-01486-9. Epub 2020 Sep 24. Adv Ther. 2020. PMID: 32970315 Free PMC article. Clinical Trial.
Pharmacokinetics and Bioequivalence of Rasagiline Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions: An Open, Randomized, Single-Dose, Double-Cycle, Two-Sequence, Crossover Trial.
Li Y, Qi L, Bai H, Liu Y, Fan R, Tu Y, Sun Y, Wang J, Qi Q, Feng X, Zhou D, Wang X. Li Y, et al. Among authors: qi l, qi q. Front Pharmacol. 2020 Dec 3;11:571747. doi: 10.3389/fphar.2020.571747. eCollection 2020. Front Pharmacol. 2020. PMID: 33364947 Free PMC article. Clinical Trial.
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study.
Li Y, Qi L, Bai H, Sun C, Xu S, Wang Y, Han C, Li Y, Liu L, Cheng X, Liu J, Lei C, Tong Y, Sun M, Yan L, Chen W, Liu X, Liu Q, Xie L, Wang X. Li Y, et al. Among authors: qi l. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0106321. doi: 10.1128/AAC.01063-21. Epub 2021 Sep 7. Antimicrob Agents Chemother. 2021. PMID: 34491805 Free PMC article. Clinical Trial.
Phase I, randomized, double-blind, single-dose study to assess the pharmacokinetics, safety, and immunogenicity of the proposed biosimilar SCT630 and adalimumab in healthy Chinese subjects.
Liu L, Qi L, Lei C, Wang Y, Zhang W, Liu Y, Li P, Bai H, Li Y, Li Y, Liu J, Xie L, Wang X. Liu L, et al. Among authors: qi l. Int Immunopharmacol. 2022 May;106:108599. doi: 10.1016/j.intimp.2022.108599. Epub 2022 Feb 19. Int Immunopharmacol. 2022. PMID: 35193054 Clinical Trial.
5,750 results